Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
4/18/2025
VelaVigo and Ollin Biosciences Ink ex-Greater China Licensing Deal for...
4/17/2025
Pharma Giants Already Moving to Cut Reliance on China Amid Tariff Unce...
4/17/2025
WuXi AppTec Cashes Out of WuXi XDC as U.S. Tariff Threats Mount
4/17/2025
Eddingpharm to Take Over Genor in HKEX's First 18A Reverse Merger
4/17/2025
Latticon Pioneers China's First Pipeline-Backed Financing Deal
4/17/2025
Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phase 3 Trial for R...
4/17/2025
Sanofi Secures Global Rights to AI-Discovered BsAb in $1.8B+ Deal with...
4/17/2025
DualityBio Raises $211M in Hong Kong IPO
4/17/2025
BMS Launches Head-to-Head Phase 1 Trial for SystImmune-Licensed EGFR/H...
4/15/2025
U.S. Tariff Threat on Chinese Pharma Could Reshape Landscape for India...
4/15/2025
Chinese Pharma Companies Rethink Global Strategies as US Considers Dru...
4/14/2025
Belief BioMed/Takeda's hemophilia B Gene Therapy BBM-H901 Approved in...
4/14/2025
iRegene Advances Chemically-Induced iPSC Platform, Pioneers Cell Thera...
4/14/2025
Sirius Receives FDA IND Clearance for FIC siRNA Therapy SRSD216 Target...
4/11/2025
YiChang HEC ChangJiang Privatization Advances with NDRC Approval, Fina...
4/10/2025
Sumitomo Pharma Transfers Asian/Chinese Operations Amid Industry-Wide ...
4/10/2025
Trump's Planned Tariffs on Imported Pharmaceuticals Target China
4/9/2025
BioDuro Expands China Operations with New R&D and Manufacturing Campus...
4/9/2025
U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...
4/8/2025
China Approves Hansoh's Ibrexafungerp for Vaginal Yeast Infections
4/8/2025
Duality Bio Upsizes IPO Amid Global Market Challenges
4/8/2025
Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...
4/8/2025
Tariffs Spark Market Jitters, But China's Innovative Drug Sector Remai...
4/8/2025
Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...
4/8/2025
TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China
4/8/2025
Rigerna Thera Advances siRNA Drug Development with Pre-A Financing
4/7/2025
Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...
4/5/2025
CASI Pharma Evaluates CEO's $40M Proposal for China Operations
4/5/2025
Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
4/5/2025
Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
Page:
1
/
21
Total number of articles:
607
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit